DeepCardio possesses the technology to analyze and present the risk of various cardiac diseases from a single ECG test.
The SmartECG solution is the core technology of DeepCardio AI.
AI Technology Overview
SmartECG is an AI solution trained on ECG data collected across diverse clinical environments.
In collaboration with Korea's leading medical institutions, it has received approval for use as a diagnostic support tool when testing for arrhythmia, heart failure, and cardiovascular disease using ECG alone.
Clinical ECG Data-Based
The AI is trained primarily on ECG data
collected from real clinical settings.
Data Quality Management
Noise removal and quality standards are applied to ensure only highly reliable data is used in analysis.
Multi-Center Research with Validation Across Institutions
Results have been validated with diverse datasets through collaborative research with Korea's leading university hospitals.
AI Analysis Method
The AI analyzes raw ECG data (XML) to comprehensively examine waveform morphology, temporal changes, and electrical characteristics, capturing signal patterns associated with disease.
ECG Raw Data
AI Analysis
Risk Presentation by Disease
Normal ECG — AI analysis indicates high likelihood of atrial fibrillation
Female, 72, March 2026
Normal ECG — AI analysis indicates high likelihood of atrial fibrillation
Female, 74, March 2026
DeepCardio's AI technology analyzes subtle signal patterns associated with cardiac disease — even in ECGs that appear normal to the naked eye — and presents the likelihood of disease.